7-Methoxy-4-(pyridin-3-yl)-6-[2-(quinolin-2-yl)ethoxy]quinazoline | 1006890-01-2 | sc-483392
| 5 mg
| $430.00
| | |
|
6,8-Dibromo-2-chloromethyl-3H-quinazolin-4-one | | sc-357952 sc-357952A
| 250 mg 1 g
| $197.00 $399.00
| | |
|
cFMS Receptor Inhibitor II | 959860-85-6 | sc-221415 sc-221415A
| 500 µg 1 mg
| $116.00 $219.00
| 2 | |
cFMS Receptor Inhibitor II 是一种细胞渗透性苯胺喹啉化合物 |
VEGFR Tyrosine Kinase Inhibitor V | 861874-34-2 anhydrous | sc-356190
| 5 mg
| $240.00
| | |
VEGFR Tyrosine Kinase Inhibitor V 是血管内皮生长因子受体活性和 HUVEC 增殖的强效拮抗剂 |
4-[(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy]butanoic acid | | sc-348524 sc-348524A
| 250 mg 1 g
| $248.00 $510.00
| | |
|
McN 5652, (+/-) | 96795-89-0 | sc-203627 sc-203627A
| 10 mg 50 mg
| $169.00 $681.00
| | |
McN 5652, (±) is a 5-HT uptake inhibitor |
tert-butyl 8-hydroxy-1,2,3,4-tetrahydroquinoline-1-carboxylate | 676255-10-0 | sc-356083 sc-356083A
| 250 mg 1 g
| $197.00 $399.00
| | |
|
Ro 04-5595 hydrochloride | 194089-07-1 | sc-204885 sc-204885A
| 10 mg 50 mg
| $165.00 $715.00
| | |
Ro 04-5595 hydrochloride 是一种选择性 NMDA 受体拮抗剂 |
7-thien-2-yl-2,3-dihydro[1,4]dioxino[2,3-g]quinoline-9-carboxylic acid | | sc-351538 sc-351538A
| 1 g 5 g
| $578.00 $1725.00
| | |
|
2-(2-Phenyl-ethenesulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid | | sc-339563 sc-339563A
| 1 g 5 g
| $334.00 $970.00
| | |
|